Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2007
05/10/2007WO2006105313A3 Compositions of and methods of using oversulfated glycosaminoglycans
05/10/2007WO2006067310A3 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain
05/10/2007US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders
05/10/2007US20070105961 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
05/10/2007US20070105949 Intermediates for the preparation of lipoxin A4 analogs
05/10/2007US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability
05/10/2007US20070105933 Amino alcohol compounds
05/10/2007US20070105913 Alkynyl aryl carboxamides
05/10/2007US20070105886 Steroidal compounds for inhibiting steroid sulphatase
05/10/2007US20070105883 Novel physiologically active substances pf127oa, b and c substances
05/10/2007US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors
05/10/2007US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors
05/10/2007US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/10/2007US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/10/2007US20070105850 2,4-diChloro-N-(4-cyclopropylmethanesulfonyl-1-cyclopropylmethylcyclohexyl-methyl) benzamide; glutamatergic neurotransmission dysfunction and diseases; dementia; antidepressants; learning enhancement; cognition activators; attention deficit disorders; autism; eating disorders; anxiolytic agents
05/10/2007US20070105127 DNA libraries comprising vector constructs coding glycosylation enzymes and organelle targeting signal sequences for use in modifying exogenously expressed polypeptides
05/10/2007CA2627670A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
05/10/2007CA2627516A1 Triazole compounds as lipoxygenase inhibitors
05/10/2007CA2626350A1 Compounds and compositions as protein kinase inhibitors
05/10/2007CA2626074A1 A combination of cannabinoids for the treatment of peripheral neurophatic pain
05/10/2007CA2610480A1 Nanoparticulate acetaminophen formulations
05/09/2007EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor
05/09/2007EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis
05/09/2007EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
05/09/2007EP1783115A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use
05/09/2007EP1782834A2 Oxycodone conjugates with lower abuse potential and extended duration of action
05/09/2007EP1782808A1 Preventive or therapeutic agent for chronic inflammatory lung disease
05/09/2007EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof
05/09/2007EP1782799A2 Transdermal therapeutic system comprising an active analogue of fentanyl
05/09/2007EP1781689A1 Conjugates and therapeutic uses thereof
05/09/2007EP1781655A2 Triazolopyridine compounds useful for the treatment of inflammation
05/09/2007EP1781654A1 Pyrrolo-pyridine kinase modulators
05/09/2007EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors
05/09/2007EP1781638A2 Imidazolo-related compounds, compositions and methods for their use
05/09/2007EP1781619A1 Sigma receptor inhibitors
05/09/2007EP1781618A1 Sigma receptor inhibitors
05/09/2007EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists
05/09/2007EP1781306A2 Immune stimulatory infant nutrition
05/09/2007EP1781299A1 Anti-inflammatory agents
05/09/2007EP1781272A1 Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
05/09/2007EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors
05/09/2007EP1365788B1 Thrombomodulin analogs for use in recovery of spinal cord injury
05/09/2007EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
05/09/2007EP0937032B1 Substituted gamma aminobutyric acids as pharmaceutical agents
05/09/2007CN1960758A Remedy or preventive for arthritis
05/09/2007CN1960731A Method for regulating inflammatory and metastatic processes
05/09/2007CN1960725A Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis
05/09/2007CN1958584A Derivative of fibrauretine, and preparation method
05/09/2007CN1958064A Chinese traditional medicine for external application of treating rheumatism like disease, preparation method and usage
05/09/2007CN1958063A Method for treating arthritis by using caper
05/09/2007CN1958052A Medication for treating rheumatoid arthritis, ankylosing spondylitis
05/09/2007CN1958046A Wine for promoting blood circulation and activating the channels
05/09/2007CN1958042A Method for preparing gel for wean to remove heat
05/09/2007CN1958041A Preparation of Chinese traditional medicine for treating disease of prolapse of intervertebral disc
05/09/2007CN1958040A Composition of Chinese traditional medicine for dispelling wind-evil, activating collateral flow, strengthening the muscles and bones, preparation method and usage
05/09/2007CN1958031A New application of purple fragrant plantainlily root in preparing medication
05/09/2007CN1958029A Jingangteng solution type solid dispersion, and application
05/09/2007CN1958026A Xiaotongshu plaster, and preparation method
05/09/2007CN1958016A Composition of medication in use for clearing away heat and promoting diuresis, absorbing clots, preparation method and usage
05/09/2007CN1958010A Composition preparation of Chinese traditional medicine, and preparation method
05/09/2007CN1957994A Animal use compound medicament with effect for clearing away the heat-evil and expelling superficial evils, and preparation method
05/09/2007CN1957993A Capsule of relaxing muscles and tendons and assuaging pain of Chinese traditional medicine and preparation method
05/09/2007CN1957924A Nano liposome of tea plant oil, and preparation method
05/09/2007CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase
05/09/2007CN1314682C Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
05/09/2007CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity
05/09/2007CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase
05/09/2007CN1314442C External-applied Chinese medicine for easing pain and channels and collaterals
05/09/2007CN1314441C Plaster for relaxing the muscles and joints and its prepn process
05/09/2007CN1314438C Medication for curing stomach ache of women's menses
05/09/2007CN1314427C Medicine for treating menalgia
05/09/2007CN1314425C Chinese traditional medicine for treating rheumatoid arthritis
05/09/2007CN1314403C Composition of paeoniflorin and albiflorin and its preparation method
05/09/2007CN1314399C Child metho kahuangmin effervescent granules and its making method
05/09/2007CN1314386C Tripterygium hypoglaucum contained transdermal plaster and its preparation
05/08/2007US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
05/08/2007US7214772 Sialoadhesin family member-2 (SAF-2)
05/08/2007US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/08/2007US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer
05/08/2007US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
05/08/2007US7214688 Compounds
05/08/2007US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
05/08/2007US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
05/08/2007US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/08/2007US7214667 Drugs against articular failure
05/08/2007US7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
05/08/2007US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a
05/08/2007US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response
05/08/2007US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
05/08/2007US7213312 Funerary container made of paper material, and assembly device employed therein
05/08/2007CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
05/08/2007CA2373990C Pyrrolotriazine inhibitors of kinases
05/08/2007CA2310593C Metalloproteinase inhibitors
05/08/2007CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
05/08/2007CA2185015C Novel silyl compounds and their use
05/03/2007WO2007050271A2 5-lipoxygenase modulators
05/03/2007WO2007050034A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease